Trial intelligence / Profile preview

Renal HEALTH-STUDY

2010-021987-13Phase 3Active

Sponsor
University Medical Center Groningen
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aliskiren and ramipril in hypertension (HTN) and Glomerular Hypertension (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Renal hemodynamics. Started Sep 2010; status: active.

02

Drugs

aliskirenramipril
03

Conditions

hypertension (HTN)Glomerular Hypertension

Beyond the preview

Go deeper on 2010-021987-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021987-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call